Gene-Modified cell therapy: researchers track Long-Term safety in arthritis and skin disease patients

NCT ID NCT07123038

Recruiting now Knowledge-focused Sponsor: Sonoma Biotherapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study monitors 36 people who previously received an experimental gene-modified regulatory T cell (Treg) therapy for rheumatoid arthritis or hidradenitis suppurativa. The goal is to check for any delayed side effects and see how long the modified cells last in the body. Participants are not receiving new treatment, just being observed for safety over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA (HS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hidradenitis suppurativa rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIDRADENITIS SUPPURATIVA (HS) RHEUMATOID ARTHRITIS (RA)

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Brigham and Women's Hospital
RECRUITING

Boston, Massachusetts, 02115, United States
Duke University
NOT_YET_RECRUITING

Durham, North Carolina, 27708, United States
Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02114, United States
Northwestern University
RECRUITING

Chicago, Illinois, 60611, United States
Stanford Medical Center
RECRUITING

Stanford, California, 94305, United States
The University of Texas MD Anderson Cancer Center
NOT_YET_RECRUITING

Houston, Texas, 77030, United States
Tufts University
RECRUITING

Boston, Massachusetts, 02111, United States
UCSF Medical Center
RECRUITING

San Francisco, California, 94143, United States
University of Colorado
RECRUITING

Aurora, Colorado, 80045, United States
University of Minnesota
NOT_YET_RECRUITING

Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.